Qualigen Therapeutics(QLGN) - 2024 Q1 - Quarterly Report

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $.001 per share QLGN The Nasdaq Capital Market of The Nasdaq Stock Market LLC Securities registered pursuant to Section 12(b) of the Act: The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. FORM 10-Q For the quarterly period ended March 31, 2024 For the transition ...